Once thyroid hormone replacement achieves optimal levels, metabolic rate typically improves, facilitating weight management efforts
Depending on the timeline for development and approval for CT-PYY, other treatments may establish themselves in the market, which could affect the adoption of CT-PYY
Pause or cancel at any time
No FDA-approved domestic generic can launch until Novo Nordisk's core US patent expires in December 2031 at the earliest
Kor J Nephrol 1992;11:260-269
Validation of RNA-seq results using RT-qPCR To validate the accuracy of the RNA-seq data, six genes (Pnpla2, Lipe, Plin5, Csf1r, Col1a1, and Bmp4) were randomly selected for qPCR analysis